Jeffrey Baxter serves as President and Chief Executive Officer of VBI Vaccines Inc., a biopharmaceutical company focusing on immunology for disease prevention and treatment, since September 2009. In addition, Baxter holds a board member position at ChromaDex since April 2015. Previous experience includes managing partner at The Column Group, senior vice president of R&D finance and operations, and vice president in the office of the CEO at GlaxoSmithKline, along with various roles at Glaxo Wellcome PLC and Glaxo PLC. Baxter's career began with nine years in financial and accounting roles at Unilever PLC. Educational qualifications include multiple certifications from CIMA and a Bachelor of Science in Finance and Economics from the University of West London.
This person is not in the org chart
This person is not in any teams
This person is not in any offices